The Future is DNA: Spotlight Talk with Twist

The Future is DNA: Spotlight Talk with Twist

Thursday, October 1, 2020 3:02 PM to 3:07 PM · 5 min. (Africa/Abidjan)
October 1

Information

As we enter the century of biotechnology, our ability to read, write, and edit DNA is disrupting everything from human health to manufacturing. The next disruption to take place could be in the world of DNA synthesis. Learn about where we’ve been, where we are now, and where we are going — and what it will take to get there.
Twist BioscienceTwist Bioscience is a leading and rapidly growing synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research. Follow us on Twitter | Facebook">Facebook | LinkedIn | YouTube">YouTube 

Registered attendees

AARON HAMMONS
AARON HAMMONS
Director Business Development, Life SciencesCodexis Inc
Aaron Sato
Aaron Sato
CSOTwist
Alex Rosay
Alex Rosay
Product ManagerZymergen

Log in